Activatable fluorescent probes for in situ imaging of enzymes

X Wu, R Wang, N Kwon, H Ma, J Yoon - Chemical Society Reviews, 2022 - pubs.rsc.org
As the main biomarkers of most diseases, enzymes play fundamental but extremely critical
roles in biosystems. High-resolution studies of enzymes using activatable in situ …

Activity‐based NIR enzyme fluorescent probes for the diagnosis of tumors and image‐guided surgery

H Li, D Kim, Q Yao, H Ge, J Chung, J Fan… - Angewandte …, 2021 - Wiley Online Library
Near‐infrared (NIR) activatable fluorescent probes have been considered to be the effective
edge tools for the investigation of cell biology and disease diagnosis because of their …

Revisiting fluorescent calixarenes: from molecular sensors to smart materials

R Kumar, A Sharma, H Singh, P Suating… - Chemical …, 2019 - ACS Publications
Calix [n] arenes (n= 4, 5, 6, 8) are “chalicelike” phenol-based macrocycles that are among
the most fascinating and highly studied scaffolds in supramolecular chemistry. This stems …

Hypoxia-targeted drug delivery

A Sharma, JF Arambula, S Koo, R Kumar… - Chemical Society …, 2019 - pubs.rsc.org
Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically
associated with abnormal vasculature, which results in a reduced supply of oxygen and …

Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer

J Chen, H Luo, Y Liu, W Zhang, H Li, T Luo, K Zhang… - ACS …, 2017 - ACS Publications
Hypoxia as one characteristic hallmark of solid tumors has been demonstrated to be
involved in cancer metastasis and progression, induce severe resistance to oxygen …

Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy

J Yuan, QH Zhou, S Xu, QP Zuo, W Li… - Angewandte Chemie …, 2022 - Wiley Online Library
Tumor‐specific, hypoxia‐activated prodrugs have been developed to alleviate the side
effects of chemotherapy drugs. However, the release efficiency of hypoxia‐activated …

Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy

Y Wang, Y Xie, J Li, ZH Peng, Y Sheinin, J Zhou… - ACS …, 2017 - ACS Publications
Poor tumor penetration is a major challenge for the use of nanoparticles in anticancer
therapy. Moreover, the inability to reach hypoxic tumor cells that are distant from blood …

Sequential ultrasound-triggered and hypoxia-sensitive nanoprodrug for cascade amplification of sonochemotherapy

F Zhuang, Q Ma, C Dong, H Xiang, Y Shen, P Sun… - ACS …, 2022 - ACS Publications
Hypoxia, the typical and conspicuous characteristic of most solid tumors, worsens the tumor
invasiveness and metastasis. Here, we engineered a sequential ultrasound (US)/hypoxia …

Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy

L Feng, L Cheng, Z Dong, D Tao, TE Barnhart, W Cai… - ACS …, 2017 - ACS Publications
Photodynamic therapy (PDT), a noninvasive cancer therapeutic method triggered by light,
would lead to severe tumor hypoxia after treatment. Utilizing a hypoxia-activated prodrug …

Cancer‐associated, stimuli‐driven, turn on theranostics for multimodality imaging and therapy

X Li, J Kim, J Yoon, X Chen - Advanced Materials, 2017 - Wiley Online Library
Advances in bioinformatics, genomics, proteomics, and metabolomics have facilitated the
development of novel anticancer agents that have decreased side effects and increased …